Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e31825493eb
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2012
Authors
Publisher
Elsevier BV